For providers, those findings point to a clear opportunity: GLP-1 medication can help patients lose weight, but structured behavioral support may help them protect that progress when treatment changes or ends
Original consultation and health screening Your Semaglutide experience starts with a detailed medical evaluation at our Roland Park clinic
When therapy is appropriate, combine it with nutrition and resistance training rather than treating any single signal as the whole story
Tzang, R.F., et al
We diagnosed mucosal pigmentation associated with imatinib therapy, thus excluding other environmental, physiological, and pathological causes (Table 1)
Klausen M, Justesen S, Pedersen J et al.Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trialThe Lancet, 407, 1687-1698 Herman, Rae J